For many years, surgical resection has been the only therapeutic option for PMs, but lately targeted therapies with multi-tyrosine kinase inhibitors, MTOR inhibitors, VEGF inhibitors and immunotherapies have been shown to be extremely effective [42,43]. The gene discussed is VEGFA; the disease is premenstrual tension.